Laser Capture Microdissection and Advanced Molecular Analysis of Human Breast Cancer

[1]  M. Zvelebil,et al.  The Application of 2D Gel-Based Proteomics Methods to the Study of Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.

[2]  R. Eils,et al.  From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Tatjana Crnogorac-Jurcevic,et al.  Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer , 2003, Oncogene.

[4]  R. Salunga,et al.  Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Kornelia Polyak,et al.  Molecular markers in ductal carcinoma in situ of the breast. , 2003, Molecular cancer research : MCR.

[6]  J. Warrington,et al.  Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. , 2003, The Journal of molecular diagnostics : JMD.

[7]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[8]  R. Eeles,et al.  CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours , 2002, British Journal of Cancer.

[9]  E. Petricoin,et al.  Proteomics of human breast ductal carcinoma in situ. , 2002, Cancer research.

[10]  D. Birnbaum,et al.  Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells. , 2002, International journal of oncology.

[11]  Baogang J. Xu,et al.  Direct analysis of laser capture microdissected cells by MALDI mass spectrometry , 2002, Journal of the American Society for Mass Spectrometry.

[12]  P. V. van Diest,et al.  Analysis of the progression of fibroepithelial tumours of the breast by PCR‐based clonality assay , 2002, The Journal of pathology.

[13]  Ken Saito,et al.  Vasculogenic mimicry and pseudo‐comedo formation in breast cancer , 2002, International journal of cancer.

[14]  D. Sgroi,et al.  Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2. , 2002, Cancer research.

[15]  A. Elkahloun,et al.  In Situ Gene Expression Analysis of Cancer Using Laser Capture Microdissection, Microarrays and Real Time Quantitative PCR , 2002, Cancer biology & therapy.

[16]  Careen K. Tang,et al.  Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis , 2002, International journal of cancer.

[17]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[18]  Futoshi Akiyama,et al.  Microdissection is essential for gene expression profiling of clinically resected cancer tissues. , 2002, American journal of clinical pathology.

[19]  P. Nelson,et al.  From genomics to proteomics: techniques and applications in cancer research. , 2001, Trends in cell biology.

[20]  R. Hansen,et al.  MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  C. Paweletz,et al.  New approaches to proteomic analysis of breast cancer , 2001, Proteomics.

[22]  F. Révillion,et al.  Proteomics of breast cancer for marker discovery and signal pathway profiling , 2001, Proteomics.

[23]  A. Roquancourt,et al.  Allelic Loss Detection in Inflammatory Breast Cancer: Improvement with Laser Microdissection , 2001, Laboratory Investigation.

[24]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Lemeshow,et al.  Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. , 2001, Human molecular genetics.

[26]  K. Lunetta,et al.  HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Gazdar,et al.  Primary mammary small-cell carcinoma: a molecular analysis of 2 cases. , 2001, Human pathology.

[28]  Kylie L. Gorringe,et al.  Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers : a new approach for the molecular analysis of paraffin-embedded cancer tissue. , 2001, The American journal of pathology.

[29]  U. Lehmann,et al.  Amplification of Growth Regulatory Genes in Intraductal Breast Cancer Is Associated with Higher Nuclear Grade but Not with the Progression to Invasiveness , 2001, Laboratory Investigation.

[30]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[31]  S. Fuqua,et al.  Histological and biological evolution of human premalignant breast disease. , 2001, Endocrine-related cancer.

[32]  E. Brown,et al.  Quantitative analysis of mRNA amplification by in vitro transcription. , 2001, Nucleic acids research.

[33]  E. Dougherty,et al.  Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.

[34]  M. Shekhar,et al.  Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. , 2001, Cancer research.

[35]  S. Martino,et al.  Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow Cytometry: An Eastern Cooperative Oncology Group Study (2192) , 2001, American journal of clinical oncology.

[36]  Adrian V. Lee,et al.  High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer , 2001, British Journal of Cancer.

[37]  Kelvin H. Lee.  Proteomics : a technology-driven and technology-limited discovery science , 2001 .

[38]  W. Hahn,et al.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.

[39]  U. Lehmann,et al.  Detection of Gene Amplification in Intraductal and Infiltrating Breast Cancer by Laser-Assisted Microdissection and Quantitative Real-Time PCR , 2001, Pathobiology.

[40]  S. McLeskey,et al.  Expression and function of angiopoietin-1 in breast cancer , 2000, British Journal of Cancer.

[41]  D. Palmer-Toy,et al.  Direct acquisition of matrix-assisted laser Desorption/Ionization time-of-flight mass spectra from laser capture microdissected tissues , 2000, Clinical chemistry.

[42]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[43]  S. Gygi,et al.  Measuring gene expression by quantitative proteome analysis. , 2000, Current opinion in biotechnology.

[44]  C. Yue,et al.  Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis. , 2000, Cancer research.

[45]  Leslie W Dalton,et al.  Histologic Grading of Breast Cancer: Linkage of Patient Outcome with Level of Pathologist Agreement , 2000, Modern Pathology.

[46]  Paul A. Haynes,et al.  Proteome Profiling—Pitfalls and Progress , 2000, Yeast.

[47]  U. Lehmann,et al.  Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. , 2000, The American journal of pathology.

[48]  S. Lakhani,et al.  Comparative Genomic Hybridization Analysis of Myoepithelial Carcinoma of the Breast , 2000, Laboratory Investigation.

[49]  M J Bissell,et al.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones. , 2000, Endocrine-related cancer.

[50]  F. Marincola,et al.  High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.

[51]  M. Barcellos-Hoff,et al.  Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. , 2000, Cancer research.

[52]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[53]  K. Kölble.  The LEICA microdissection system: design and applications. , 2000, Journal of molecular medicine.

[54]  H. Höfler,et al.  Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: Evidence of genetic resemblance by CGH , 2000, International journal of cancer.

[55]  J. Hudson,et al.  In vivo gene expression profile analysis of human breast cancer progression. , 1999, Cancer research.

[56]  H. Höfler,et al.  20q13.2 Amplification in intraductal hyperplasia adjacent to in situ and invasive ductal carcinoma of the breast , 1999, Virchows Archiv.

[57]  H. Höfler,et al.  Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. , 1999, Cancer genetics and cytogenetics.

[58]  M. Bittner,et al.  Expression profiling using cDNA microarrays , 1999, Nature Genetics.

[59]  Georgia Lahr,et al.  Identification of expressed genes by laser-mediated manipulation of single cells , 1998, Nature Biotechnology.

[60]  L. Liotta,et al.  Laser-capture microdissection: opening the microscopic frontier to molecular analysis. , 1998, Trends in genetics : TIG.

[61]  Robert F. Bonner,et al.  Laser Capture Microdissection: Molecular Analysis of Tissue , 1997, Science.

[62]  C. Larabell,et al.  Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies , 1997, The Journal of cell biology.

[63]  J. Seilhamer,et al.  A comparison of selected mRNA and protein abundances in human liver , 1997, Electrophoresis.

[64]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[65]  M J Bissell,et al.  The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. , 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[66]  L. Liotta,et al.  Laser capture microdissection. , 2006, Methods in molecular biology.

[67]  M. J. van de Vijver,et al.  Ductal carcinoma in situ: a proposal for a new classification. , 1994, Seminars in diagnostic pathology.

[68]  J. Foidart,et al.  Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. , 1993, British Journal of Cancer.

[69]  D. Page,et al.  Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. , 1992, Human pathology.

[70]  J. Price,et al.  Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. , 1990, Cancer research.

[71]  M. Chevallier,et al.  Distribution of the major connective matrix components of the stromal reaction in breast carcinoma. An immunohistochemical study. , 1987, Cellular and molecular biology.

[72]  D. Medina,et al.  Preferential growth of mammary tumors in intact mammary fatpads. , 1981, Cancer research.